Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/50325
Title: Preparation of cross-linked carboxymethyl jackfruit starch and evaluation as a tablet disintegrant
Authors: Nisit Kittipongpatana
Suwakon Janta
Ornanong Kittipongpatana
Authors: Nisit Kittipongpatana
Suwakon Janta
Ornanong Kittipongpatana
Keywords: Pharmacology, Toxicology and Pharmaceutics
Issue Date: 1-Oct-2011
Abstract: The main purposes of this study are to prepare cross-linked carboxymethyl jackfruit starch (CL-CMJF) and to evaluate its pharmaceutical property as a tablet disintegrant. CL-CMJF was prepared by a dual carboxymethylcrosslinking reaction in a flask containing jackfruit seed starch (JFS), chloroacetic acid (CAA), sodium hydroxide (NaOH) and sodium trimetaphosphate (STMP). The reaction was carried out using methanol as a solvent for 60 min at 70° C and at JFS:CAA:NaOH:STMP ratio of 1.0:0.29:0.28:0.07. The obtained CL-CMJF, with degree of substitution and degree of crosslinking calculated to be 0.34 and 0.06, respectively, was insoluble but swellable in water. Rheological study revealed a decreased in solution viscosity compared to the non-crosslinked CMJF. The water uptake of CL-CMJF was 23 times higher than that of native starch and was comparable to that of a commercial superdisintegrant, sodium starch glycolate (SSG). The swelling ability of CL-CMRS was similar to that of crosscarmellose sodium (CCS), another commercial superdisintegrant. Disintegration test of aspirin tablets containing 2%w/w of JFS, CL-CMJF, SSG and CCS showed disintegration times in the order of SSG < CCS ∼ CL-CMJF ⋘ JFS. The results suggested that CL-CMJF could be developed as a tablet disintegrant.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=80053455606&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/50325
ISSN: 1011601X
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.